Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriane Fugh-Berman

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
American Family Physician|July 2, 2010
Prescribing evidence: the efficacy and safety of new drugsAdriane Fugh-Berman
The American Journal of Nursing|February 26, 2016
Advise Against FlibanserinAdriane Fugh-Berman
Plos Biology|November 22, 2013
How basic scientists help the pharmaceutical industry market drugsAdriane Fugh-Berman
BMJ (Clinical Research Ed.)|June 5, 2021
Industry-funded medical education is always promotion-an essay by Adriane Fugh-BermanAdriane Fugh-Berman
BMJ (Clinical Research Ed.)|July 18, 2008
Key opinion leaders: Thus are our medical meetings managedAdriane Fugh-Berman
Journal of General Internal Medicine|September 17, 2009
Don't be 'mis-led': few herbal products have been implicated in lead poisoningAdriane Fugh-Berman
Annals of Internal Medicine|January 2, 2008
Prescriber profilingAdriane Fugh-Berman
Journal of General Internal Medicine|May 14, 2008
Prescription tracking and public healthAdriane Fugh-Berman
The New England Journal of Medicine|March 10, 2009
Rosuvastatin in patients with elevated C-reactive proteinAdriane Fugh-Berman
American Family Physician|May 9, 2015
Should family physicians screen for testosterone deficiency in men? No: screening may be harmful, and benefits are unprovenAdriane Fugh-Berman
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
American Family Physician|July 2, 2010
Prescribing evidence: the efficacy and safety of new drugsAdriane Fugh-Berman
The American Journal of Nursing|February 26, 2016
Advise Against FlibanserinAdriane Fugh-Berman
Plos Biology|November 22, 2013
How basic scientists help the pharmaceutical industry market drugsAdriane Fugh-Berman
BMJ (Clinical Research Ed.)|June 5, 2021
Industry-funded medical education is always promotion-an essay by Adriane Fugh-BermanAdriane Fugh-Berman
BMJ (Clinical Research Ed.)|July 18, 2008
Key opinion leaders: Thus are our medical meetings managedAdriane Fugh-Berman
Journal of General Internal Medicine|September 17, 2009
Don't be 'mis-led': few herbal products have been implicated in lead poisoningAdriane Fugh-Berman
Annals of Internal Medicine|January 2, 2008
Prescriber profilingAdriane Fugh-Berman
Journal of General Internal Medicine|May 14, 2008
Prescription tracking and public healthAdriane Fugh-Berman
The New England Journal of Medicine|March 10, 2009
Rosuvastatin in patients with elevated C-reactive proteinAdriane Fugh-Berman
American Family Physician|May 9, 2015
Should family physicians screen for testosterone deficiency in men? No: screening may be harmful, and benefits are unprovenAdriane Fugh-Berman
Pageof 7